United Kingdom

Sihuan Pharmaceutical Holdings Group Ltd (0460.HK)

0460.HK on Hong Kong Stock

15 Feb 2018
Change (% chg)

-- (--)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Latest Key Developments (Source: Significant Developments)

Sihuan Pharmaceutical says unit to invest in Pharmadax Foshan
Monday, 4 Sep 2017 

Sept 4 (Reuters) - Sihuan Pharmaceutical Holdings Group Ltd <0460.HK>:Hainan Sihuan Pharmaceutical, a unit of co, recently entered into agreements with Pharmadax Inc.In first phase, group will subscribe for 19.99% equity interests in and corporate bonds issued by, Pharmadax Foshan at rmb200 million.  Full Article

Sihuan Pharmaceutical Holdings Group says HY revenue RMB 1.39 billion, down 21.8 pct<0460.HK>
Tuesday, 23 Aug 2016 

Sihuan Pharmaceutical Holdings Group Ltd <0460.HK>: Announcement of interim results for the six months ended 30 June 2016 <0460.HK> . HY profit attributable to owners of the company decreased by 49.3% to approximately RMB736.0 million . Interim dividend of RMB1.4 cents per share was declared by the board . It is expected that the government will maintain tight control over excessive growth in medical expenditure . Says HY revenue RMB 1.39 billion, down 21.8% . Lowering of provincial drug tender prices and implementation of "two-invoice system" to continue to pressure the pharmaceutical industry . Says rigid demand in the domestic pharmaceutical market will continue to grow .  Full Article